U.S. Markets closed

Today's Research Reports on Trending Tickers: Spark Therapeutics and PTC Therapeutics

NEW YORK, NY / ACCESSWIRE / August 15, 2018 /U.S. equities snapped losses on Tuesday, as panic over Turkey’s currency eased and market participants focused on upbeat corporate earnings and strong economic data. The NFIB’s (National Federation of Independent Business) small-business optimism index rose 0.7 points in July, its 2nd-highest level ever. The Dow Jones Industrial Average increased 0.45 percent to close at 25,299.92, while the S&P 500 Index gained 0.64 percent to close at 2,839.96. The Nasdaq Composite Index climbed 0.65 percent to close at 7,870.89.

“I think that you’re getting a bounce today because of the action of the past couple of days,” according to Robert Pavlik, chief investment strategist at SlateStone Wealth LLC. “But I wouldn’t be rushing into things because it has to play out,” Pavlik added.

RDI Initiates Coverage on:

Spark Therapeutics, Inc.
https://rdinvesting.com/news/?ticker=ONCE

PTC Therapeutics, Inc.
https://rdinvesting.com/news/?ticker=PTCT

Spark Therapeutics' stock jumped 4.87% Tuesday, to close the day at $61.35. The stock recorded a trading volume of 673,784 shares, which was below its three months average volume of 690,531 shares. In the last year, Spark Therapeutics' shares have traded in a range of 41.06 - 96.59. The share price has gained 49.42% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $79.09 is above its 200-day moving average of $71.76. Shares of Spark Therapeutics have fallen roughly 27.8 percent in the past month and are up 19.31 percent year-to-date.

Access RDI's Spark Therapeutics, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=ONCE

On Tuesday, shares of PTC Therapeutics recorded a trading volume of 724,752 shares, which was below the three months average volume of 1,301,814 shares. The stock ended the day 4.06% higher at $44.89. The share price has fallen 15.22% from its 52 week high with a 52 week trading range of 14.56 - 52.95. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $37.10 is above its 200-day moving average of $31.30. Shares of PTC Therapeutics have gained roughly 23.8 percent in the past month and are up 169.12 percent year-to-date.

Access RDI's PTC Therapeutics, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=PTCT

Our Actionable Research on Spark Therapeutics, Inc. (NASDAQ : ONCE ) and PTC Therapeutics, Inc. (NASDAQ : PTCT ) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com